AstraZeneca reiterated on Wednesday that its Covid-19 vaccine was very effective at preventing the disease, based on more recent data than was included when the company announced the interim results of its U.S. clinical trial on Monday. nyti.ms
@forbes.com4 years ago
Johnson & Johnson Vaccine’s 66% Efficacy Figure Is Better Than It Looks
